Milestone brief
Material changes in clinical registries, publications, regulatory records and developer disclosures, with the evidence type stated explicitly.
Service research
We are assessing demand for a structured, source-linked service for clinics, researchers, life-science companies, investors and analysts.
Sample issue · September 2026
The sample shows the reporting structure, evidence labels and level of interpretation. It uses current public information and contains no treatment recommendation.
Proposed coverage
Material changes in clinical registries, publications, regulatory records and developer disclosures, with the evidence type stated explicitly.
Companies, technology classes, study status and source history in a format suitable for internal review and citation.
What a new result changes, what it does not establish and which evidence would be required next.
The proposed service would not recommend treatments, sell leads, accept paid rankings or present company statements as clinical evidence. The current open Development Index shows the underlying editorial approach.